glp 1 & gip Science Behind and Glucagon Receptor Agonists for Obesity Research | News Announcements Personalized GLP-1/GIP + B12 -
Description
Mrinalika RoyandSriparna Roy
Probiotics: Lacticaseibacillus rhamnosus, Limosilactobacillus reuteri, Bifidobacterium longum subsp
GLP-1 receptor agonists are widely prescribed for diabetes and obesity, populations at elevated risk for steatotic liver disease, yet fibrosis risk assessment remains inconsistently applied, delaying cirrhosis detection and management
Clinician-written guides on GLP-1s, phentermine, metabolism, safe weight loss, and progress tracking
